TOP1 and cancer: Apparently, the presence of a keto-group in the monoterpene scaffold has a negative effect on TDP1 inhibition, but not on the ability to potentiate topotecan, a TOP1 poison, since all the compounds tested have a synergistic effect, which is, at least partly, due to the presence of other mechanisms that enhance topotecan cytotoxicity towards cancer cells.